ID   PRP4B_HUMAN             Reviewed;        1007 AA.
AC   Q13523; A8K5C9; Q5D0F6; Q5TAY8; Q8IVC3; Q8TDP2; Q96QT7; Q9UEE6;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   15-MAR-2017, entry version 187.
DE   RecName: Full=Serine/threonine-protein kinase PRP4 homolog;
DE            EC=2.7.11.1;
DE   AltName: Full=PRP4 kinase;
DE   AltName: Full=PRP4 pre-mRNA-processing factor 4 homolog;
GN   Name=PRPF4B; Synonyms=KIAA0536, PRP4, PRP4H, PRP4K;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND VARIANT VAL-83.
RX   PubMed=11418604; DOI=10.1074/jbc.M103790200;
RA   Kojima T., Zama T., Wada K., Onogi H., Hagiwara M.;
RT   "Cloning of human PRP4 reveals interaction with Clk1.";
RL   J. Biol. Chem. 276:32247-32256(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-83.
RX   PubMed=12077342; DOI=10.1128/MCB.22.14.5141-5156.2002;
RA   Dellaire G., Makarov E.M., Cowger J.J.M., Longman D.,
RA   Sutherland H.G.E., Luehrmann R., Torchia J., Bickmore W.A.;
RT   "Mammalian PRP4 kinase copurifies and interacts with components of
RT   both the U5 snRNP and the N-CoR deacetylase complexes.";
RL   Mol. Cell. Biol. 22:5141-5156(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-83.
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-83.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 512-1007.
RX   PubMed=9102632; DOI=10.1093/nar/25.5.1028;
RA   Gross T., Lutzelberger M., Wiegmann H., Klingenhoff A., Shenoy S.,
RA   Kaeufer N.F.;
RT   "Functional analysis of the fission yeast Prp4 protein kinase involved
RT   in pre-mRNA splicing and isolation of a putative mammalian
RT   homologue.";
RL   Nucleic Acids Res. 25:1028-1035(1997).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   SPLICEOSOMAL C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/S1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-32; SER-87;
RP   SER-93; SER-277; SER-366 AND SER-368, VARIANT [LARGE SCALE ANALYSIS]
RP   VAL-83, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-23; SER-32;
RP   TYR-140; SER-142; SER-144; SER-257; SER-277; SER-427; SER-431;
RP   SER-437; SER-569; SER-578; SER-580 AND TYR-849, VARIANT [LARGE SCALE
RP   ANALYSIS] VAL-83, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, VARIANT [LARGE SCALE
RP   ANALYSIS] VAL-83, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-23; SER-32;
RP   TYR-140; SER-142; SER-144; SER-518; SER-578 AND SER-580, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-717, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-23; SER-32;
RP   SER-87; SER-93; SER-239; SER-241; SER-257; SER-277; SER-283; SER-366;
RP   SER-368; SER-431; SER-518; SER-519; SER-520; SER-565; SER-578; SER-580
RP   AND TYR-849, VARIANT [LARGE SCALE ANALYSIS] VAL-83, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-23; SER-32;
RP   SER-87; SER-93; SER-142; SER-144; SER-277; SER-294; SER-328; SER-354;
RP   SER-356; SER-366; SER-368; THR-385; SER-387; SER-431; SER-518;
RP   SER-519; SER-520; SER-578; SER-580 AND TYR-849, VARIANT [LARGE SCALE
RP   ANALYSIS] VAL-83, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-23; SER-87;
RP   SER-93; SER-166; SER-277; SER-292; SER-294; SER-366; SER-368; SER-427;
RP   SER-431 AND SER-437, VARIANT [LARGE SCALE ANALYSIS] VAL-83, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-142; SER-257;
RP   SER-277 AND TYR-849, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117 AND LYS-170, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [26]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-658.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [27]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-584 AND LEU-658.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Has a role in pre-mRNA splicing. Phosphorylates SF2/ASF.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Identified in the spliceosome C complex. Interacts with
CC       Clk1 C-terminus. {ECO:0000269|PubMed:11991638}.
CC   -!- INTERACTION:
CC       P49407:ARRB1; NbExp=2; IntAct=EBI-395940, EBI-743313;
CC       P32121:ARRB2; NbExp=3; IntAct=EBI-395940, EBI-714559;
CC       P04590:gag (xeno); NbExp=6; IntAct=EBI-395940, EBI-780156;
CC       Q9Y2Y9:KLF13; NbExp=5; IntAct=EBI-395940, EBI-1255893;
CC       Q9H1D9:POLR3F; NbExp=2; IntAct=EBI-395940, EBI-710067;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Phosphorylated by Clk1.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH09844.1; Type=Frameshift; Positions=432; Evidence={ECO:0000305};
CC       Sequence=BAA25462.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY029347; AAK38155.1; -; mRNA.
DR   EMBL; AF283465; AAM19101.1; -; mRNA.
DR   EMBL; AB011108; BAA25462.1; ALT_INIT; mRNA.
DR   EMBL; AK291244; BAF83933.1; -; mRNA.
DR   EMBL; AL138831; CAI20480.1; -; Genomic_DNA.
DR   EMBL; AL033383; CAI20480.1; JOINED; Genomic_DNA.
DR   EMBL; AL033383; CAI42121.1; -; Genomic_DNA.
DR   EMBL; AL138831; CAI42121.1; JOINED; Genomic_DNA.
DR   EMBL; CH471087; EAW55146.1; -; Genomic_DNA.
DR   EMBL; BC009844; AAH09844.1; ALT_FRAME; mRNA.
DR   EMBL; BC034969; AAH34969.1; -; mRNA.
DR   EMBL; U48736; AAB03268.1; -; mRNA.
DR   CCDS; CCDS4488.1; -.
DR   RefSeq; NP_003904.3; NM_003913.4.
DR   RefSeq; XP_016866899.1; XM_017011410.1.
DR   RefSeq; XP_016866900.1; XM_017011411.1.
DR   RefSeq; XP_016866901.1; XM_017011412.1.
DR   RefSeq; XP_016866902.1; XM_017011413.1.
DR   RefSeq; XP_016866903.1; XM_017011414.1.
DR   RefSeq; XP_016866904.1; XM_017011415.1.
DR   RefSeq; XP_016866905.1; XM_017011416.1.
DR   RefSeq; XP_016866906.1; XM_017011417.1.
DR   RefSeq; XP_016866907.1; XM_017011418.1.
DR   RefSeq; XP_016866908.1; XM_017011419.1.
DR   RefSeq; XP_016866909.1; XM_017011420.1.
DR   RefSeq; XP_016866910.1; XM_017011421.1.
DR   RefSeq; XP_016866911.1; XM_017011422.1.
DR   RefSeq; XP_016866912.1; XM_017011423.1.
DR   RefSeq; XP_016866913.1; XM_017011424.1.
DR   RefSeq; XP_016866914.1; XM_017011425.1.
DR   RefSeq; XP_016866915.1; XM_017011426.1.
DR   RefSeq; XP_016866916.1; XM_017011427.1.
DR   RefSeq; XP_016866917.1; XM_017011428.1.
DR   RefSeq; XP_016866918.1; XM_017011429.1.
DR   RefSeq; XP_016866919.1; XM_017011430.1.
DR   RefSeq; XP_016866920.1; XM_017011431.1.
DR   UniGene; Hs.159014; -.
DR   PDB; 4IAN; X-ray; 2.44 A; A/B=657-1007.
DR   PDB; 4IFC; X-ray; 2.13 A; A/B=657-1007.
DR   PDB; 4IIR; X-ray; 2.00 A; A/B=657-1007.
DR   PDB; 4IJP; X-ray; 2.25 A; A/B=657-1007.
DR   PDBsum; 4IAN; -.
DR   PDBsum; 4IFC; -.
DR   PDBsum; 4IIR; -.
DR   PDBsum; 4IJP; -.
DR   ProteinModelPortal; Q13523; -.
DR   SMR; Q13523; -.
DR   BioGrid; 114416; 63.
DR   IntAct; Q13523; 42.
DR   MINT; MINT-1379795; -.
DR   STRING; 9606.ENSP00000337194; -.
DR   BindingDB; Q13523; -.
DR   ChEMBL; CHEMBL1908382; -.
DR   GuidetoPHARMACOLOGY; 2177; -.
DR   iPTMnet; Q13523; -.
DR   PhosphoSitePlus; Q13523; -.
DR   SwissPalm; Q13523; -.
DR   BioMuta; PRPF4B; -.
DR   DMDM; 317373526; -.
DR   EPD; Q13523; -.
DR   MaxQB; Q13523; -.
DR   PaxDb; Q13523; -.
DR   PeptideAtlas; Q13523; -.
DR   PRIDE; Q13523; -.
DR   DNASU; 8899; -.
DR   Ensembl; ENST00000337659; ENSP00000337194; ENSG00000112739.
DR   Ensembl; ENST00000480058; ENSP00000433547; ENSG00000112739.
DR   GeneID; 8899; -.
DR   KEGG; hsa:8899; -.
DR   UCSC; uc003mvv.4; human.
DR   CTD; 8899; -.
DR   DisGeNET; 8899; -.
DR   GeneCards; PRPF4B; -.
DR   H-InvDB; HIX0005547; -.
DR   HGNC; HGNC:17346; PRPF4B.
DR   HPA; HPA020638; -.
DR   MIM; 602338; gene.
DR   neXtProt; NX_Q13523; -.
DR   OpenTargets; ENSG00000112739; -.
DR   PharmGKB; PA38447; -.
DR   eggNOG; KOG0670; Eukaryota.
DR   eggNOG; ENOG410XPAX; LUCA.
DR   GeneTree; ENSGT00760000119032; -.
DR   HOVERGEN; HBG055182; -.
DR   InParanoid; Q13523; -.
DR   KO; K08827; -.
DR   OMA; SGERDRY; -.
DR   OrthoDB; EOG091G095F; -.
DR   PhylomeDB; Q13523; -.
DR   TreeFam; TF315246; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   SignaLink; Q13523; -.
DR   SIGNOR; Q13523; -.
DR   ChiTaRS; PRPF4B; human.
DR   GeneWiki; PRPF4B; -.
DR   GenomeRNAi; 8899; -.
DR   PRO; PR:Q13523; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112739; -.
DR   CleanEx; HS_PRPF4B; -.
DR   ExpressionAtlas; Q13523; baseline and differential.
DR   Genevisible; Q13523; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0005694; C:chromosome; IEA:Ensembl.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome;
KW   Isopeptide bond; Kinase; mRNA processing; mRNA splicing;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Spliceosome;
KW   Transferase; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2   1007       Serine/threonine-protein kinase PRP4
FT                                homolog.
FT                                /FTId=PRO_0000086586.
FT   DOMAIN      687   1006       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     693    701       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS     39    496       Arg/Lys-rich (basic).
FT   COMPBIAS     40     78       His-rich.
FT   ACT_SITE    815    815       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     717    717       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5RKH1}.
FT   MOD_RES      20     20       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      23     23       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      32     32       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES      87     87       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      93     93       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      99     99       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q61136}.
FT   MOD_RES     131    131       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     140    140       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     142    142       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     144    144       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     166    166       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     239    239       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     241    241       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     257    257       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     277    277       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     283    283       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     292    292       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     294    294       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     328    328       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     354    354       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     366    366       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     368    368       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     385    385       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     387    387       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     427    427       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     431    431       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     437    437       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     518    518       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     519    519       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     520    520       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     565    565       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     569    569       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     578    578       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     580    580       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     717    717       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     849    849       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     852    852       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5RKH1}.
FT   CROSSLNK    117    117       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    117    117       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297}.
FT   CROSSLNK    170    170       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VARIANT      83     83       I -> V (in dbSNP:rs9503893).
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11418604,
FT                                ECO:0000269|PubMed:12077342,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:9628581}.
FT                                /FTId=VAR_046969.
FT   VARIANT     584    584       I -> V (in dbSNP:rs56267049).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_047798.
FT   VARIANT     658    658       F -> L (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_035633.
FT   CONFLICT    468    468       P -> T (in Ref. 7; AAH34969).
FT                                {ECO:0000305}.
FT   CONFLICT    610    610       K -> R (in Ref. 4; BAF83933).
FT                                {ECO:0000305}.
FT   CONFLICT    754    754       F -> L (in Ref. 7; AAH34969).
FT                                {ECO:0000305}.
FT   CONFLICT    851    851       V -> F (in Ref. 7; AAH34969).
FT                                {ECO:0000305}.
FT   STRAND      671    673       {ECO:0000244|PDB:4IIR}.
FT   TURN        684    686       {ECO:0000244|PDB:4IIR}.
FT   STRAND      687    694       {ECO:0000244|PDB:4IIR}.
FT   STRAND      697    699       {ECO:0000244|PDB:4IJP}.
FT   STRAND      700    706       {ECO:0000244|PDB:4IIR}.
FT   HELIX       707    709       {ECO:0000244|PDB:4IIR}.
FT   STRAND      713    718       {ECO:0000244|PDB:4IIR}.
FT   HELIX       724    742       {ECO:0000244|PDB:4IIR}.
FT   STRAND      753    759       {ECO:0000244|PDB:4IIR}.
FT   STRAND      762    767       {ECO:0000244|PDB:4IIR}.
FT   HELIX       774    781       {ECO:0000244|PDB:4IIR}.
FT   TURN        783    785       {ECO:0000244|PDB:4IAN}.
FT   HELIX       789    808       {ECO:0000244|PDB:4IIR}.
FT   HELIX       818    820       {ECO:0000244|PDB:4IIR}.
FT   STRAND      821    823       {ECO:0000244|PDB:4IIR}.
FT   STRAND      830    832       {ECO:0000244|PDB:4IIR}.
FT   STRAND      839    842       {ECO:0000244|PDB:4IIR}.
FT   HELIX       853    855       {ECO:0000244|PDB:4IIR}.
FT   HELIX       858    862       {ECO:0000244|PDB:4IIR}.
FT   HELIX       869    884       {ECO:0000244|PDB:4IIR}.
FT   HELIX       894    905       {ECO:0000244|PDB:4IIR}.
FT   HELIX       910    915       {ECO:0000244|PDB:4IIR}.
FT   TURN        920    922       {ECO:0000244|PDB:4IIR}.
FT   STRAND      929    932       {ECO:0000244|PDB:4IIR}.
FT   STRAND      943    947       {ECO:0000244|PDB:4IIR}.
FT   HELIX       955    959       {ECO:0000244|PDB:4IIR}.
FT   HELIX       967    983       {ECO:0000244|PDB:4IIR}.
FT   HELIX       988    990       {ECO:0000244|PDB:4IFC}.
FT   HELIX       994    998       {ECO:0000244|PDB:4IIR}.
FT   HELIX      1001   1004       {ECO:0000244|PDB:4IIR}.
SQ   SEQUENCE   1007 AA;  116987 MW;  EC8C1538A61EDA78 CRC64;
     MAAAETQSLR EQPEMEDANS EKSINEENGE VSEDQSQNKH SRHKKKKHKH RSKHKKHKHS
     SEEDKDKKHK HKHKHKKHKR KEIIDASDKE GMSPAKRTKL DDLALLEDLE KQRALIKAEL
     DNELMEGKVQ SGMGLILQGY ESGSEEEGEI HEKARNGNRS STRSSSTKGK LELVDNKITT
     KKRSKSRSKE RTRHRSDKKK SKGGIEIVKE KTTRSKSKER KKSKSPSKRS KSQDQARKSK
     SPTLRRRSQE KIGKARSPTD DKVKIEDKSK SKDRKKSPII NESRSRDRGK KSRSPVDLRG
     KSKDRRSRSK ERKSKRSETD KEKKPIKSPS KDASSGKENR SPSRRPGRSP KRRSLSPKPR
     DKSRRSRSPL LNDRRSKQSK SPSRTLSPGR RAKSRSLERK RREPERRRLS SPRTRPRDDI
     LSRRERSKDA SPINRWSPTR RRSRSPIRRR SRSPLRRSRS PRRRSRSPRR RDRGRRSRSR
     LRRRSRSRGG RRRRSRSKVK EDKFKGSLSE GMKVEQESSS DDNLEDFDVE EEDEEALIEQ
     RRIQRQAIVQ KYKYLAEDSN MSVPSEPSSP QSSTRTRSPS PDDILERVAA DVKEYERENV
     DTFEASVKAK HNLMTVEQNN GSSQKKLLAP DMFTESDDMF AAYFDSARLR AAGIGKDFKE
     NPNLRDNWTD AEGYYRVNIG EVLDKRYNVY GYTGQGVFSN VVRARDNARA NQEVAVKIIR
     NNELMQKTGL KELEFLKKLN DADPDDKFHC LRLFRHFYHK QHLCLVFEPL SMNLREVLKK
     YGKDVGLHIK AVRSYSQQLF LALKLLKRCN ILHADIKPDN ILVNESKTIL KLCDFGSASH
     VADNDITPYL VSRFYRAPEI IIGKSYDYGI DMWSVGCTLY ELYTGKILFP GKTNNHMLKL
     AMDLKGKMPN KMIRKGVFKD QHFDQNLNFM YIEVDKVTER EKVTVMSTIN PTKDLLADLI
     GCQRLPEDQR KKVHQLKDLL DQILMLDPAK RISINQALQH AFIQEKI
//
